EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension
Clinical trial NCT03497689 · COMPLETED
Trial details
- NCT number
- NCT03497689
- Sponsor
- United Therapeutics
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-31
- Primary completion
- 2022-05-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.